30. März 2023 – The suspension of the establishment licences and medicinal product authorisations of Amino AG became legally enforceable on 8 December 2022. As a result, the manufacture of medicinal products was no longer possible and medicinal products under the name Amino AG could no longer be distributed. After Swissmedic’s acceptance of the new Qualified Person (QP) at the end of January 2023 and the company’s implementation of measures for distribution in accordance with the regulations, Swissmedic is lifting the suspension of the establishment licence for distribution activities and of the medicinal product authorisations with immediate effect. The manufacturing licence remains suspended until the deficiencies identified in an inspection in August 2022 are remedied.

For more information, see here.